|
ES2193133T3
(es)
*
|
1991-07-13 |
2003-11-01 |
Dade Behring Marburg Gmbh |
Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines.
|
|
GB9207701D0
(en)
*
|
1992-04-08 |
1992-05-27 |
Cancer Res Campaign Tech |
Papillomavirus e7 protein
|
|
IL105554A
(en)
|
1992-05-05 |
1999-08-17 |
Univ Leiden |
Peptides of human papillomavirus for use in preparations elicit a human T cell response
|
|
GB9306731D0
(en)
*
|
1993-03-31 |
1993-05-26 |
Cancer Res Campaign Tech |
Vaccines
|
|
JP4303315B2
(ja)
|
1994-05-09 |
2009-07-29 |
オックスフォード バイオメディカ（ユーケー）リミテッド |
非交差性レトロウイルスベクター
|
|
US6013517A
(en)
*
|
1994-05-09 |
2000-01-11 |
Chiron Corporation |
Crossless retroviral vectors
|
|
AUPN015794A0
(en)
|
1994-12-20 |
1995-01-19 |
Csl Limited |
Variants of human papilloma virus antigens
|
|
WO1996026277A1
(en)
*
|
1995-02-24 |
1996-08-29 |
Cantab Pharmaceuticals Research Limited |
Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
|
|
AUPN443995A0
(en)
*
|
1995-07-27 |
1995-08-17 |
Csl Limited |
Papillomavirus polyprotein
|
|
FI990157A0
(fi)
*
|
1996-07-29 |
1999-01-28 |
Cantab Pharma Res |
Immunoterapeuttisina aineina käyttökelpoisia polypeptidejä sekä polypeptidivalmistuksen menetelmiä
|
|
GB9717953D0
(en)
*
|
1997-08-22 |
1997-10-29 |
Smithkline Beecham Biolog |
Vaccine
|
|
DE19925199A1
(de)
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
|
DE19925235A1
(de)
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
|
EP2100620A1
(en)
*
|
1999-09-16 |
2009-09-16 |
Eisai Corporation of North America |
Nucleic acids encoding polyepitope polypeptides
|
|
AU2007201619B2
(en)
*
|
1999-09-16 |
2011-05-12 |
Eisai Inc. |
Nucleic acids encoding polyepitope polypeptides
|
|
US8128922B2
(en)
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
EP1363938B1
(en)
|
2000-08-03 |
2013-12-11 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
CA2498776A1
(en)
*
|
2002-09-13 |
2004-03-25 |
The University Of Queensland |
Gene expression system based on codon translation efficiency
|
|
WO2004098526A2
(en)
|
2003-05-05 |
2004-11-18 |
Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
WO2006073970A2
(en)
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
|
WO2006081323A2
(en)
*
|
2005-01-26 |
2006-08-03 |
The Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US8466259B2
(en)
|
2007-12-07 |
2013-06-18 |
National Health Research Institutes |
Adjuvants
|
|
US8426163B2
(en)
|
2007-12-07 |
2013-04-23 |
National Health Research Institutes |
Production of lipidated proteins in E. coli
|
|
US8287880B2
(en)
|
2009-06-02 |
2012-10-16 |
National Health Research Institutes |
Lipidated vaccine against dengue virus infection
|
|
WO2010148496A1
(en)
|
2009-06-22 |
2010-12-29 |
National Health Research Institutes |
Lipidated tumor- associated antigens and immunotherapeutic compositions
|
|
TW201221642A
(en)
|
2010-11-15 |
2012-06-01 |
Nat Health Research Institutes |
Method of producing lipidated polypeptides
|
|
TWI507413B
(zh)
|
2010-11-15 |
2015-11-11 |
Nat Health Research Institutes |
脂質化多抗原表位疫苗
|
|
KR20140076613A
(ko)
*
|
2011-10-12 |
2014-06-20 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
인간 파필로마 바이러스에 대한 백신 및 이것을 사용하는 방법
|
|
AU2014248535B2
(en)
|
2013-03-12 |
2017-03-30 |
Inovio Pharmaceuticals, Inc. |
Improved vaccines for human papilloma virus and methods for using the same
|
|
WO2016149643A2
(en)
*
|
2015-03-18 |
2016-09-22 |
Omnicyte |
Fusion proteins comprising modified alpha virus surface glycoproteins and tumor associated antigen and methods thereof
|
|
CN110914295B
(zh)
|
2017-06-28 |
2024-08-09 |
里珍纳龙药品有限公司 |
抗人乳头瘤病毒(hpv)抗原结合蛋白及其使用方法
|